Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
Key Highlights
- ➤Q3 net revenue $1,493.5 million, up 4.1% year over year
- ➤Q3 GAAP diluted EPS $0.38, up 18.8% year over year
- ➤Q3 adjusted EBITDA $124.6 million, up 4.3% year over year
- ➤Option Care Health will be acquired by Clayton, Dubilier & Rice and McKesson
- ➤Company withdrew previously disclosed financial guidance amid pending acquisition
BANNOCKBURN, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2026.
(year-over-year comparisons unless otherwise noted) * Net revenue of $1,493.5 million, up 4.1% * GAAP net income of $57.4 million, up 10.8% * GAAP diluted earnings per share of $0.38, up 18.8% * Adjusted EBITDA of $124.6 million, up 4.3% * Adjusted diluted earnings per share of $0.49, up 8.9% * Cash provided by Q3 operating activities of $114.7 million As previously announced, the Company has entered into a definitive merger agreement pursuant to which it will be acquired by Clayton, Dubilier & Rice, LLC and McKesson Corporation. Given the pending acquisition, the Company will not host an earnings conference call in connection with these results and has withdrawn its previously disclosed financial guidance.
Get started
Create a free account to read the full story.